This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Merck Patent Gmbh, Pfizer Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: Klaus Schneider: Innovator in Diagnostic Antibodies
Introduction
Klaus Schneider is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of diagnostics, particularly in the development of antibodies that target specific proteins in human tissues. His work has implications for patient stratification and personalized medicine.
Latest Patents
Klaus Schneider holds a patent for a "Diagnostic anti-PD-L1 antibody and use thereof." This invention provides an antibody or antigen-binding fragment that binds to an epitope within human PD-L1 with high specificity and reproducibility. The inventive antibody can be utilized in assessing PD-L1 expression in tissue samples, aiding in the stratification of patients. Additionally, the patent outlines methods for producing this innovative antibody.
Career Highlights
Throughout his career, Klaus Schneider has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in medical diagnostics.
Collaborations
Klaus Schneider has collaborated with esteemed colleagues, including Claudia Wilm and Heike Dahmen. Their combined expertise has furthered the development of innovative solutions in the field of diagnostics.
Conclusion
Klaus Schneider's contributions to the field of diagnostic antibodies exemplify the impact of innovation in medicine. His work continues to influence patient care and treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile